Injectable self-assembled GDF5-containing dipeptide hydrogels for enhanced tendon repair.

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Orthopedic Surgery

Background:

• Tendon injuries pose significant challenges due to poor vascularization and cellularity, impacting motor function and quality of life.
• Current treatments often result in adhesion and scar formation, hindering effective tissue regeneration.

Purpose of the Study:

• To develop an injectable dipeptide hydrogel (DPH) system for enhanced tendon regeneration.
• To investigate the efficacy of incorporating growth differentiation factor 5 (GDF5) into the DPH (GDF5@DPH) for promoting tendon healing.

Main Methods:

• Fabrication of a self-assembling dipeptide hydrogel (DPH) using polypeptides P11-4 and P11-8.
• Incorporation of varying concentrations of growth differentiation factor 5 (GDF5) to create GDF5@DPH.
• Evaluation of GDF5@DPH's effects on tendon stem/progenitor cell aggregation, differentiation, and tissue repair in vitro.

Main Results:

• GDF5@DPH successfully promoted the aggregation and differentiation of tendon stem/progenitor cells.
• The GDF5@DPH system enhanced the regeneration of tendon cells and collagen fibers in injured areas.
• GDF5@DPH demonstrated an ability to inhibit inflammatory responses and reduce adhesion/scar hyperplasia.

Conclusions:

• The injectable GDF5@DPH system offers a promising new therapeutic strategy for tendon injury treatment.
• This approach provides a favorable microenvironment for tendon tissue repair and regeneration.
• GDF5@DPH holds potential for improving clinical outcomes in patients with tendon injuries.